- Home
- NVCT vs SOL Comparison
NVCT vs SOL Comparison
Compare NVCT & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- SOL
- Stock Information
- Founded
- NVCT 2020
- SOL 2005
- Country
- NVCT United States
- SOL United States
- Employees
- NVCT N/A
- SOL N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- SOL Semiconductors
- Sector
- NVCT Health Care
- SOL Technology
- Exchange
- NVCT Nasdaq
- SOL Nasdaq
- Market Cap
- NVCT 119.4M
- SOL 97.4M
- IPO Year
- NVCT 2022
- SOL 2008
- Fundamental
- Price
- NVCT $4.52
- SOL $1.83
- Analyst Decision
- NVCT Strong Buy
- SOL Buy
- Analyst Count
- NVCT 1
- SOL 3
- Target Price
- NVCT $21.00
- SOL $3.83
- AVG Volume (30 Days)
- NVCT 94.6K
- SOL 212.0K
- Earning Date
- NVCT 11-05-2024
- SOL 11-14-2024
- Dividend Yield
- NVCT N/A
- SOL N/A
- EPS Growth
- NVCT N/A
- SOL N/A
- EPS
- NVCT N/A
- SOL N/A
- Revenue
- NVCT N/A
- SOL $102,489,000.00
- Revenue This Year
- NVCT N/A
- SOL N/A
- Revenue Next Year
- NVCT N/A
- SOL $46.42
- P/E Ratio
- NVCT N/A
- SOL N/A
- Revenue Growth
- NVCT N/A
- SOL 25.98
- 52 Week Low
- NVCT $4.44
- SOL $1.41
- 52 Week High
- NVCT $12.10
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- NVCT 37.50
- SOL 43.76
- Support Level
- NVCT $4.48
- SOL $1.75
- Resistance Level
- NVCT $5.34
- SOL $1.98
- Average True Range (ATR)
- NVCT 0.37
- SOL 0.13
- MACD
- NVCT 0.07
- SOL 0.01
- Stochastic Oscillator
- NVCT 8.89
- SOL 40.11
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.